StockKit ResearchEQUITY RESEARCH BRIEF
AMGN · US · Fresh
Generated 2026-09-06 23:40 UTC
AMGN
AMGN · US
$376.26
+0.06%
Technical posture
Constructive
Strategy score
61 / 100
Trend
bull
Data confidence
High
Research view
AMGN Research Preview
1. Bottom line
- AMGN (AMGN) is trading at 376.26, with a current daily move of +0.06%.
- The StockKit strategy score is 61/100, creating a neutral research posture with bullish alignment (ma5 > ma10 > ma20 > ma60).
- The most important near-term watch zone is support at 346.63 and resistance at 416.87; price is +7.88% from support and +10.79% from resistance.
2. Key data snapshot
| Item | Reading | Interpretation |
|---|---:|---|
| Current price | 376.26 | Daily move +0.06% |
| Strategy score | 61/100 | Buy, trend: bull |
| MA structure | Bullish alignment (MA5 > MA10 > MA20 > MA60) | The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure. |
| RSI14 | 74.25 | Elevated / potential short-term exhaustion |
| MACD | 3.18 histogram | Bullish MACD configuration |
| Support / resistance | 346.63 / 416.87 | Watch these levels for confirmation or failure |
| 30-session range | 353.95 / 418.40 | Price sits at +34.62% of the range |
| Volume check | -27.67% vs 20D avg | Confirmation quality depends on volume follow-through |
| ATR14 / price | +3.10% | Proxy for short-term volatility risk |
3. Technical indicator panel
- Trend: The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure.
- Momentum: RSI14 is in an elevated zone, so chasing strength carries higher short-term risk.
- MACD: histogram is 3.18, while MACD line / signal are 13.18 / 10.00.
- KDJ: K / D / J are 82.73 / 75.97 / 96.26; KDJ constructive crossover.
- Bollinger: Mid-band zone (42% of band); upper / middle / lower are 416.87 / 381.75 / 346.63.
- ATR / OBV / CCI: ATR14 is 12.93 (+3.10% of price), OBV slope is +107.05%, and CCI20 is 153.39.
- Levels: estimated support / resistance are 346.63 / 416.87; recent 30-session range is 353.95 / 418.40.
4. Valuation matrix
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 26.45 | SEC EDGAR companyfacts | Medium |
| PB | 17.45 | SEC EDGAR companyfacts | Medium |
| Price / sales | 5.55 | SEC EDGAR companyfacts | Medium |
| EV/EBITDA | 17.35 | SEC EDGAR companyfacts | Low |
| PEG proxy | 4.74 | StockKit scenario model | Medium |
| StockKit fair value range | Bear $183.56 / Base $237.45 / Bull $304.16 | StockKit DCF scenario model | Medium |
| Base fair-value gap | -36.9% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear -0.42% / Base +5.58% / Bull +11.58% | StockKit scenario model | Medium |
| Revenue | $36.75B | SEC EDGAR companyfacts | High |
| Net income | $7.71B | SEC EDGAR companyfacts | High |
| Market cap | $203.93B | SEC shares outstanding + live quote | Medium |
| Balance sheet context | Assets $95.64B / Equity $11.69B | SEC EDGAR companyfacts | High |
Notes: - SEC CIK: 0000318154; company: AMGEN INC. - Latest annual income-statement period used where available: 2025-12-31. - PEG and fair-value range are StockKit scenario outputs computed from reported fundamentals; they are not analyst consensus targets.
5. News and catalyst timeline
1. Is Gilead Sciences Stock Outperforming the S&P 500? - Barchart.com
2. Amgen Stock Signals Its Confidence. The Market Agrees. - Trefis
3. AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE - PRNewswire
4. 川普與逾20家全球藥廠達成降價協議，折扣最高達85% - Yahoo Entertainment
6. Sentiment radar
5 recent headlines available; no provider-level sentiment score was supplied.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 5 headlines | Barchart.com x1, Trefis x1, PRNewswire x1 | Medium |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
Notes: - No provider sentiment series was returned for this symbol.
7. Scenario framework
| Scenario | Trigger condition | Confirmation signal | Invalidation signal |
|---|---|---|---|
| Base case | Price remains between 346.63 and 416.87 | Strategy score stays near 61/100 and RSI avoids extremes | Close below support or a rapid score deterioration |
| Upside case | Price clears 416.87 | Improving MACD histogram and volume above 20D average | Failed breakout back below resistance |
| Downside case | Price breaks 346.63 | RSI weakens and MACD remains negative | Quick recovery back above support |
8. Risk matrix
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical failure | Support at 346.63 anchors the current setup | Close below support | Reassess trend and reduce confidence in base case |
| Momentum exhaustion | Elevated / potential short-term exhaustion; MACD state: Bullish MACD configuration | RSI extension or MACD rollover | Watch next 1-3 closes and histogram direction |
| Volatility expansion | ATR14 / price is +3.10% | Wide ranges without follow-through | Require confirmation before trusting a directional move |
| News/data gap | 5 current news items available | New headline or missing catalyst context | Refresh news before relying on stale views |
9. Seven-day watch checklist
- First watch: whether price respects 346.63 or starts accepting below it.
- Breakout watch: whether price can clear 416.87 with volume confirmation above the 20-session average.
- Momentum watch: whether RSI14 stays constructive without moving into an exhaustion zone.
- Risk watch: whether fresh news changes the catalyst picture.
Strategy cross-check
| Strategy | Score | Signal | Basis |
|---|---|---|---|
| MA交叉 | 90/100 | StrongBuy | MA5>MA20金叉，多头排列 |
| MACD背离 | 85/100 | StrongBuy | MACD金叉，MACD在零轴上方，动能增强 |
| RSI极值 | 15/100 | StrongSell | RSI14=74超买，短期极度超买 |
| 布林带 | 40/100 | Hold | 突破上轨，短期超买，带宽扩张中 |
Information-use note
StockKit provides market research tools for informational and educational use. The output does not constitute personalized investment advice or a recommendation to buy, sell, or hold any security.
Strategy factors
MA交叉Strong momentum
90
MA5>MA20金叉，多头排列
MACD背离Strong momentum
85
MACD金叉，MACD在零轴上方，动能增强
RSI极值Deteriorating
15
RSI14=74超买，短期极度超买
布林带Neutral
40
突破上轨，短期超买，带宽扩张中
量价关系Neutral
55
价涨量缩，上涨力度不足
News & catalyst inputs
Is Gilead Sciences Stock Outperforming the S&P 500?
Barchart.com · 2026-09-03
Amgen Stock Signals Its Confidence. The Market Agrees.
Trefis · 2026-09-02
AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE
PRNewswire · 2026-09-02
川普與逾20家全球藥廠達成降價協議，折扣最高達85%
Yahoo Entertainment · 2026-09-01
Jim Cramer: This Little-Talked-About Drug Could Target the “Biggest Market of All Time” Aside From Eli Lilly’s GLP-1 Drugs
24/7 Wall St. · 2026-09-01
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.
Disclaimer.This brief is generated by StockKit AI from public market data and algorithmic models for informational research only. It is not investment advice, an offer, or a solicitation, and it does not provide buy, sell, or hold ratings, price targets, stop-loss levels, or position sizing. “Watch levels” and “scenarios” describe observable conditions in the supplied data, not instructions. Verify all information with primary sources before any investment decision.